ViroPharma - M&A Summary, Ownership, and Business Overview

Life ScienceCompany

ViroPharma M&A Summary

ViroPharma has acquired 3 companies of its own.

ViroPharma’s largest acquisition to date was in 2008, when it acquired Lev Pharmaceuticals for $586M. ViroPharma has acquired in 1 US state, and 3 countries. The Company’s most targeted sectors include life science (100%).

ViroPharma Ownership

Who owns ViroPharma?

ViroPharma is owned by Shire. It was acquired on November 11, 2013.

ViroPharma Business Overview

Where is ViroPharma headquartered?

ViroPharma is headquartered in Exton, Pennsylvania.

What sector is ViroPharma in?

ViroPharma is a life science company.

When was ViroPharma founded?

ViroPharma was founded in 1994.

M&A Summary

  • M&A Total Activity3
    • M&A Buy Activity3
  • Total Sectors Invested 1
  • Total Countries Invested 3
  • M&A Advisors 3

ViroPharma, Inc.

730 Stockton Drive,
Exton, Pennsylvania 19341
United States,
(610) 458-7300
www.viropharma.com

ViroPharma, Inc. is a pharmaceutical company committed to the commercialization, development, and discovery of new antiviral medicines.


M&A Summary

Buy vs Sell

Year ≤ '06 '07 '08 '09 '10 '11 T
Buy (0.6/yr) # - - 1 - 1 1 3
vol $586M $164M $750M
Sell (0.0/yr) # - - - - - - 0
  3

Most Recent M&A

Company Date Value Type
DuoCort Pharma AB 2011-11-15 164M USD Add-on Acquisition
Helsingborg, Sweden · www.duocort.com
Auralis Ltd. 2010-05-28 - Add-on Acquisition
Halton, United Kingdom · www.auralis.co.uk
Lev Pharmaceuticals, Inc. 2008-10-21 586M USD Add-on Acquisition
New York, New York
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 3 (100%) 750M (100%) - -
Total 3 $750M - -

By Geo

State/Country Buy Value Sell Value
Sweden 1 164M - -
United Kingdom 1 - - -
United States 1 586M - -
  New York 1 586M - -
Domestic 1 (33%) 586M (78%) - -
Cross-border 2 (67%) 164M (22%) - -
Total 3 $750M - -

Top M&A Advisors

Financial Deals
BMO Capital Markets
1
J.P. Morgan Securities
1
Legal Deals
DLA Piper
1

Deal Values

buy # Total
$100M to $1B 2 $750M
TOTAL $750M
Largest Lev Pharmaceuticals, Inc.
$586M (2008-10-21)

 Subscribe to unlock this and 208,055
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.